Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 23, 2025CancersOpen Access

Strategies to Target the Tumor-Associated Macrophages in the Immunosuppressive Microenvironment of Pancreatic Ductal Adenocarcinoma

View Full Paper
Ask AI
Bookmark
Share

Authors

RMRyu MatsumotoKagoshima UniversityKTKiyonori TanoueKagoshima UniversityCNChieri NakayamaKagoshima University

Discussion

Loading...

Member takes

Implication

This review highlights the role of tumor-associated macrophages in immune evasion in pancreatic ductal adenocarcinoma, suggesting innovative immunotherapeutic strategies.

Key Points

  • Targeting tumor-associated macrophages may enhance immune response in pancreatic ductal adenocarcinoma.
  • Evidence suggests that macrophage activity influences immune evasion mechanisms in PDAC.
  • Recent studies on CAR macrophage therapy show potential promise in treating solid tumors.
  • Understanding macrophage roles could unlock new therapeutic strategies for pancreatic cancer.

Cite This Study

Matsumoto et al. (2025) studied this question.

synapsesocial.com/papers/68d473a631b076d99fa6beachttps://doi.org/10.3390/cancers17183090
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Single cell transcriptomic analyses implicate an immunosuppressive tumor microenvironment in pancreatic cancer liver metastasis2023 · 208 citations
  2. 2CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy2022 · 668 citations
  3. 3Targeting Macrophages in Cancer: From Bench to Bedside2018 · 529 citations
  4. 4Chimeric antigen receptor macrophages targeting c-MET(CAR-M-c-MET) inhibit pancreatic cancer progression and improve cytotoxic chemotherapeutic efficacy2024 · 43 citations
  5. 5In vivo generation of CAR macrophages via the enucleated mesenchymal stem cell delivery system for glioblastoma therapy2025 · 32 citations